Medtronic PLC
(NYSE : MDT)

( )
MDT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-0.87%516.782.4%$452.42m
MDTMedtronic PLC
-0.44%88.030.6%$375.13m
ABTAbbott Laboratories
-0.71%63.330.8%$332.30m
ABMDABIOMED, Inc.
-0.59%423.483.3%$308.23m
ALGNAlign Technology, Inc.
1.37%375.386.3%$287.28m
TMOThermo Fisher Scientific Inc.
0.38%216.891.0%$282.17m
BDXBecton, Dickinson and Company
0.03%247.051.1%$248.99m
BSXBoston Scientific Corporation
0.13%33.771.1%$192.51m
EWEdwards Lifesciences Corporation
1.55%152.611.2%$170.15m
BAXBaxter International Inc.
0.36%75.011.7%$169.83m
SYKStryker Corporation
0.86%174.341.3%$165.26m
COOCooper Companies, Inc.
0.26%248.632.2%$106.36m
WATWaters Corporation
-0.23%197.183.4%$102.73m
ZBHZimmer Biomet Holdings, Inc.
-0.53%111.651.7%$98.04m
IDXXIDEXX Laboratories, Inc.
2.19%248.143.7%$97.78m

Company Profile

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.